GJC1 identification as a prognostic marker for glioma, particularly its enrichment in the cell-cycle pathway as revealed through KEGG and GO analyses, provides valuable insights into the molecular mechanisms underlying glioma progression. The gene discussed is GJC1; the disease is glioma.